The predominant expression of MAP4K4 in neuronal tissues raises the question as to whether MAP4K4 in primary brain tumors is implicated in similar or related pathophysiological processes as in neurodegenerative disorders, and whether we could learn from MAP4K4 functions in neurodegeneration to better treat brain tumor patients in the future. Here, MAP4K4 is linked to brain neoplasm.